MLSS - Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
2024-05-16 20:56:04 ET
Milestone Scientific Inc. (MLSS)
Q1 2024 Results Conference Call
May 16, 2024 08:30 AM ET
Company Participants
David Waldman - Investor Relations
Arjan Haverhals - Chief Executive Officer
Keisha Harcum - Controller
Conference Call Participants
Anthony Vendetti - the Maxim Group
Presentation
Operator
Good morning, everyone, and welcome to the Milestone Scientific Inc. First Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode and we’ll open for questions following the presentation. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, David Waldman, Cresendo Communications. The floor is yours.
David Waldman
Good morning, and thank you for joining Milestone Scientific's first quarter 2024 financial results conference call. On the call with us today are Arjan Haverhals, Chief Executive Officer; and Keisha Harcum, Vice President, Finance of Milestone Scientific.
The Company issued a press release this morning containing first quarter 2024 financial results, which is also posted on the Company's website. If you have any questions after the call, would like any additional information about the Company, please contact Crescendo Communications at (212) 671-1020. The Company's management will now provide prepared remarks reviewing the financial and operational results for quarter ended March 31, 2024.
Before we get started, we'd like to remind everyone that during this conference call, we may make forward-looking statements regarding timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth changes in our operating expenses and adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer market requirements and standards and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's report on Form 10-K for the year ended December 31, 2023, milestones we report on Form 10-Q for the first quarter ended March 31, 2024....
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript